Citation Impact
Citing Papers
Commensal Bifidobacterium promotes antitumor immunity and facilitates anti–PD-L1 efficacy
2015 StandoutScience
Antitumor Activity of the Glutaminase Inhibitor CB-839 in Triple-Negative Breast Cancer
2014
Systemic Targeting of CpG-ODN to the Tumor Microenvironment with Anti–neu-CpG Hybrid Molecule and T Regulatory Cell Depletion Induces Memory Responses in BALB-neuT Tolerant Mice
2008 StandoutNobel
Natural History of Epstein‐Barr Virus Infection in a Prospective Pediatric Cohort Born to Human Immunodeficiency Virus‐Infected Mothers
1998
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
2004 Standout
New insights into T cell biology and T cell‐directed therapy for autoimmunity, inflammation, and immunosuppression
2010
Epstein‐barr virus antibody patterns preceding the diagnosis of non‐hodgkin's lymphoma
1991
A Randomized, Double-Masked, Placebo-Controlled Study of Alicaforsen, an Antisense Inhibitor of Intercellular Adhesion Molecule 1, for the Treatment of Subjects With Active Crohn’s Disease
2007
Ulcerative Colitis
2011 Standout
TLR-dependent and TLR-independent pathways of type I interferon induction in systemic autoimmunity
2007 StandoutNobel
The history, properties, and biological effects of cachectin
1988 StandoutNobel
Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart Failure
1990 Standout
Renal-Cell Carcinoma
1996 Standout
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Metabolism and action of amino acid analog anti-cancer agents
1990
An Expanded Set of Amino Acid Analogs for the Ribosomal Translation of Unnatural Peptides
2007 StandoutNobel
A comparison of nonoperative vs. preoperative radiotherapy in rectal carcinoma
1989
Inflammatory Bowel Disease
2009 Standout
Development of an Ultrasensitive Noncompetitive Hybridization–Ligation Enzyme-Linked Immunosorbent Assay for the Determination of Phosphorothioate Oligodeoxynucleotide in Plasma
2002
Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer
1994
Intratumoral modulation of the inducible co-stimulator ICOS by recombinant oncolytic virus promotes systemic anti-tumour immunity
2017 StandoutNobel
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study
2016 Standout
Oxaliplatin, Fluorouracil, and Leucovorin as Adjuvant Treatment for Colon Cancer
2004 Standout
A CAT reporter construct allows ultrasensitive estimation of TNF synthesis, and suggests that the TNF gene has been silenced in non-macrophage cell lines.
1991 StandoutNobel
Inflammatory Bowel Disease
2002 Standout
Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left‐sided ulcerative colitis: a randomized, double‐blind, active‐controlled trial
2006
Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine
2016 StandoutNobel
Differential role of selectins in experimental colitis
2001
The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia.
1992 StandoutNobel
A Phase II dose ranging, double‐blind, placebo‐controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left‐sided ulcerative colitis
2006
Coley's toxins, tumor necrosis factor and cancer research: A historical perspective
1994
Helicobacter pylori Infection and Gastric Lymphoma
1994 Standout
Apoptosis
2002 Standout
Cellular Distribution of Phosphorothioate Oligonucleotide Following Intravenous Administration in Mice
1998
Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma
1990 Standout
Evolving knowledge and therapy of inflammatory bowel disease
2006
Epstein-Barr Virus Coinfection and Recombination in Non-Human Immunodeficiency Virus-Associated Oral Hairy Leukoplakia
1995
Revealing the world of RNA interference
2004 StandoutNatureNobel
CpG DNA and LPS induce distinct patterns of activation in human monocytes
1999
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease
2002
Antisense Pharmacodynamics: Critical Issues in the Transport and Delivery of Antisense Oligonucleotides
1999
A Phase I trial of h-ras antisense oligonucleotide ISIS 2503 administered as a continuous intravenous infusion in patients with advanced carcinoma
2001
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
2006 Standout
The effect of insulin on glucose and protein metabolism in the forearm of cancer patients
1992
Vinblastine fails to improve response of renal cancer to interferon alfa-n1: high response rate in patients with pulmonary metastases.
1991
Molecular mechanisms of action of antisense drugs
1999
Pathogen Recognition and Innate Immunity
2006 Standout
A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis
2004
Epstein–Barr Virus Infection
2000 Standout
Adjuvant Therapy of Colorectal Cancer
1988
Iron Catalysis in Organic Synthesis
2015 Standout
Constitutive synthesis of tumor necrosis factor in the thymus.
1992 StandoutNobel
Noncovalent Functionalization of Graphene and Graphene Oxide for Energy Materials, Biosensing, Catalytic, and Biomedical Applications
2016 Standout
Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation.
1988 StandoutNobel
A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity.
1991 StandoutNobel
Epstein-Barr Virus Infections: Biology, Pathogenesis, and Management
1993
A review of cancer cachexia and abnormal glucose metabolism in humans with cancer.
1992
Practical Methodologies for the Synthesis of Indoles
2006 Standout
Progress in the Delivery of Therapeutic Oligonucleotides: Organ/Cellular Distribution and Targeted Delivery of OligonucleotidesIn Vivo
2003
Synthesis of 11-amino-substituted-9-methoxy-5-methyl-6H-pyrido[4,3-b]-carbazoles
1991
Occurrence, Biogenesis, and Synthesis of Biologically Active Carbazole Alkaloids
2012 Standout
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
CpG Motifs in Bacterial DNA and Their Immune Effects
2002 Standout
Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems
2001 StandoutNobel
Cachectin: More Than a Tumor Necrosis Factor
1987 StandoutNobel
Preparative Cytoreductive Surgery in Patients with Metastatic Renal Cell Carcinoma Treated with Adoptive Immunotherapy with Interleukin-2 or Interleukin-2 Plus Lymphokine Activated Killer Cells
1990
IMMUNOTHERAPY FOR METASTATIC RENAL CELL CARCINOMA
1993
Monoclonal Antibody-Mediated Tumor Regression by Induction of Apoptosis
1989 StandoutScience
Therapeutic effect of intracolonically administered nuclear factorκB (p65) antisense oligonucleotide on mouse dextran sulphate sodium (DSS)-induced colitis
2000
Nucleic-acid therapeutics: basic principles and recent applications
2002
Interferon treatment of renal cell carcinoma. Current status and future prospects
1987
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
1993 StandoutScience
The Intestinal Microvasculature as a Therapeutic Target in Inflammatory Bowel Disease
2006
Recombinant human tumor necrosis factor induces acute reductions in food intake and body weight in mice.
1988
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
Tumors secreting human TNF/cachectin induce cachexia in mice
1987
Phase II study of 9-hydroxy-2N-methylellipticinium acetate
1984
Alternative Cleavage of the Cachectin/Tumor Necrosis Factor Propeptide Results in a Larger, Inactive Form of Secreted Protein
1989 StandoutNobel
Applications of Palladium-Catalyzed C–N Cross-Coupling Reactions
2016 Standout
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
2011
Loading of an anti-cancer drug onto graphene oxide and subsequent release to DNA/RNA: a direct optical detection
2013
Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells.
1996 StandoutNobel
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Enzymatic aminoacylation of tRNA with unnatural amino acids
2006 StandoutNobel
Improved Survival with Preoperative Radiotherapy in Resectable Rectal Cancer
1997 Standout
Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon
1989
Metabolic Approaches to Cancer Cachexia
1982
Free Radicals in the Physiological Control of Cell Function
2002 Standout
Isolation and Synthesis of Biologically Active Carbazole Alkaloids
2002 Standout
Works of Daniel L. Kisner being referenced
Interferon-alpha therapy of renal cancer.
1984
Cachexia of malignancy.Potential role of insulin in nutritional management
1979
Elliptinium, a DNA intercalating agent with broad antitumor activity in a human tumor cloning system
1987
A placebo-controlled trial of ICAM-1 antisense oligonucleotide in the treatment of Crohn's disease
1998
Enhanced Serological and Virological Findings of Epstein-Barr Virus in Patients with AIDS and AIDS-Related Complex
1986
Phase I Safety and Pharmacokinetic Profile of an Intercellular Adhesion Molecule-1 Antisense Oligodeoxynucleotide (ISIS 2302)
1997
Analysis of adjuvant therapy in large bowel cancer.
1978
The Rediscovery of DON (6-Diazo-5-oxo-L-norleucine)
1980
Chemotherapy of large intestinal carcinoma. Current results and future prospects
2006
Phase I clinical study of 9-hydroxy-2N-methyl-ellipticinium acetate (NSC-264137) administered on a 5-day i.v. schedule
1982
Alfa-2b interferon in the treatment of Hodgkin's disease and non-Hodgkin's lymphoma.
1987